Clinical Trial Update: CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial evaluating Calfactant for acute lung injury in pediatric stem cell transplant and oncology patients has completed; results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury

Drugs mentioned

• Calfactant (calfactant)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Acute Lung Injury | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2018-03-16